查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1711608

流感疫苗市場分析及預測（至 2034 年）：類型、產品、技術、應用、最終用戶、流程、部署、功能、形式、階段

Influenza Vaccine Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Process, Deployment, Functionality, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 334 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

流感疫苗市場預計將從 2024 年的 82 億美元成長到 2034 年的 145 億美元，複合年成長率約為 5.9%。該市場包括針對對公共衛生至關重要的流感病毒的疫苗的開發、製造和分銷。該市場受到季節性流感流行、政府疫苗接種計劃以及疫苗技術進步（包括基於雞蛋和基於細胞的製造方法）的推動。不斷提高的認知和不斷改善的醫療保健基礎設施，重點是提高疫苗的有效性和可及性，正在推動市場成長。

市場概覽

流感疫苗市場具有不同的特點，每個部分都為其強勁成長做出了貢獻。成人市場已成為一個關鍵市場，這主要是因為人們對流感對健康影響的認知不斷提高，並且成年人口中疫苗接種計劃的採用率不斷提高。政府致力於提高疫苗接種覆蓋率和開發提供廣譜保護的先進疫苗的舉措進一步加強了這一優勢。兒科病房規模雖然不大，但由於家長意識的提高和針對兒童的公共衛生宣傳活動的發展，其發展勢頭正在增強。一個新興的子區隔是四價疫苗，它可以對四種流感病毒株提供免疫力，並且由於其功效的提高而顯示出巨大的潛力。此外，不含雞蛋的重組疫苗的興起為雞蛋過敏人群提供了一種有希望的替代方案，有助於實現市場多元化。綜合起來，這些趨勢顯示市場格局將呈現動態，並將繼續擴張和創新。

市場區隔
類型 三價和四價疫苗
產品 去活化疫苗、活疫苗、重組疫苗
科技 基於卵子、細胞的重組DNA
應用 兒童、成人、老人、孕婦
最終用戶 醫院、診所、藥局、社區中心、研究機構
流程 製造、分銷和儲存
擴張 本地部署，雲端基礎
功能 免疫抗原性、安全性和有效性
模式 肌肉注射、鼻腔注射、皮內注射
步 臨床前試驗、臨床試驗、上市後監測

流感疫苗市場主要由去活化疫苗部分驅動，儘管減毒活病毒疫苗也佔有重要地位。這種細分受到功效、安全性和不同人群的不同需求等因素的影響。從地區來看，北美憑藉強大的醫療保健基礎設施和意識提升計劃仍然處於領先地位，而亞太地區則因政府舉措不斷增加和醫療保健投資不斷增加而出現需求激增。

賽諾菲、葛蘭素史克和 CSL Limited 等產業巨頭不斷透過研發增強其產品組合。監管的影響是巨大的，尤其是在美國和歐洲，嚴格的指導方針確保了疫苗的安全性和有效性，並塑造了市場動態。由於疫苗生產和分銷技術的進步，預計未來市場將會擴大。關注流行病防範和開發通用疫苗提供了有利可圖的機會。然而，供應鏈物流和疫苗猶豫等挑戰依然存在，需要採取策略性干預措施來維持成長。

主要趨勢和促進因素：

由於人們對感染疾病和疫苗接種重要性的認知不斷提高，流感疫苗市場正在強勁成長。主要趨勢包括開發提供廣泛保護和持久免疫的下一代疫苗。疫苗生產的技術進步，例如基於細胞和重組基因的技術，正在簡化生產流程並提高疫苗的有效性。

COVID-19 疫情凸顯了疫苗在公共衛生中的重要作用，並導致對疫苗研究和基礎設施的投資增加。世界各國政府都將流感疫苗接種計畫作為全面應對流行病的策略的一部分。此外，新興國家疫苗接種計劃的擴大也對市場成長做出了重大貢獻。

更重視針對特定族群的個人化疫苗接種，從而提高了疫苗的接種率和有效性。數位健康平台擁有大量機會，可以促進疫苗宣傳活動的有效分發和監測。創新疫苗接種方法（例如無針接種）的公司預計將搶佔大量市場佔有率。隨著生物技術的不斷進步，流感疫苗市場預計將持續擴張，以應對季節性流感和潛在的大流行威脅。

限制與挑戰：

流感疫苗市場面臨一些重大的市場限制和挑戰。一個主要問題是流感季節性，它會導致需求波動並使生產計畫變得複雜。由於錯誤訊息和對製藥公司的不信任，人們對疫苗猶豫不決，進一步限制了市場滲透。此外，疫苗研發成本高昂，對新參與企業構成重大障礙，抑制技術創新。嚴格的核准程序等監管障礙減緩了新疫苗的上市速度。此外，疫苗株需要不斷更新以跟上病毒的快速變異，這給製造商帶來了持續的財務和後勤負擔。總的來說，這些挑戰阻礙了市場成長和准入，影響了控制流感爆發的公共衛生努力。

目錄

第1章流感疫苗市場概述

  • 研究目標
  • 流感疫苗市場定義和範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章執行摘要

第3章重要考察

第4章流感疫苗市場展望

  • 流感疫苗市場區隔
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • 安索夫矩陣

第5章流感疫苗市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 最新進展

第6章流感疫苗市場規模

  • 流感疫苗市場規模（以價值計算）
  • 流感疫苗市場規模（按數量）

第7章 流感疫苗市場（依類型）

  • 市場概覽
  • 三價疫苗
  • 四價疫苗
  • 其他

第8章流感疫苗市場（依產品）

  • 市場概覽
  • 去活化疫苗
  • 活病毒疫苗
  • 重組疫苗
  • 其他

9. 流感疫苗市場（依技術）

  • 市場概覽
  • 雞蛋為主
  • 基於細胞
  • 重組DNA
  • 其他

第 10 章流感疫苗市場（依應用）

  • 市場概覽
  • 孩子們
  • 成人
  • 老年人
  • 孕婦
  • 其他

第 11 章 流感疫苗市場（依最終用戶）

  • 市場概覽
  • 醫院
  • 診所
  • 藥局
  • 社區中心
  • 研究所
  • 其他

第12章流感疫苗市場（依工藝）

  • 市場概覽
  • 製造業
  • 分配
  • 貯存
  • 其他

第13章 流感疫苗市場（依類型）

  • 市場概覽
  • 本地
  • 雲端基礎
  • 其他

第14章流感疫苗市場（依功能）

  • 市場概覽
  • 免疫抗原性
  • 安全
  • 效力
  • 其他

第15章 流感疫苗市場（依形式）

  • 市場概覽
  • 肌肉注射
  • 鼻腔
  • 皮內
  • 其他

第16章 流感疫苗市場分階段

  • 市場概覽
  • 臨床前試驗
  • 臨床試驗
  • 上市後監測
  • 其他

第17章 流感疫苗市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章競爭格局

  • 概述
  • 市場佔有率分析
  • 主要企業定位
  • 衝突領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第19章 公司簡介

  • Seqirus
  • Sanofi Pasteur
  • GlaxoSmithKline
  • AstraZeneca
  • BioDiem
  • FluGen
  • Novavax
  • Medicago
  • Bharat Biotech
  • Serum Institute of India
  • Sinovac Biotech
  • CureVac
  • Moderna
  • Inovio Pharmaceuticals
  • Altimmune
  • Vaxart
  • Dynavax Technologies
  • Valneva
  • Emergent BioSolutions
  • CSL Limited
簡介目錄
Product Code: GIS21920

Influenza Vaccine Market is anticipated to expand from $8.2 billion in 2024 to $14.5 billion by 2034, growing at a CAGR of approximately 5.9%. The market encompasses the development, production, and distribution of vaccines targeting influenza viruses, crucial for public health. This market is driven by seasonal flu outbreaks, governmental immunization programs, and advancements in vaccine technology, including egg-based and cell-based production methods. Increasing awareness and healthcare infrastructure improvements are propelling market growth, with a focus on enhancing vaccine efficacy and accessibility.

Market Overview

The Influenza Vaccine Market is characterized by distinct segments, each contributing to its robust growth. The adult segment emerges as the leading segment, primarily driven by heightened awareness of influenza's health implications and the increasing adoption of vaccination programs among the adult population. This dominance is further bolstered by government initiatives aimed at enhancing vaccine coverage and the development of advanced vaccines offering broader protection. The pediatric segment, while smaller, is gaining momentum due to growing parental awareness and public health campaigns targeting children. Emerging sub-segments include quadrivalent vaccines, which provide immunity against four influenza virus strains, demonstrating significant potential due to their enhanced efficacy. Additionally, the rise of recombinant vaccines, which are produced without the use of eggs, offers a promising alternative for those with egg allergies and contributes to the market's diversification. These trends collectively underscore a dynamic market landscape poised for continued expansion and innovation.

Market Segmentation
TypeTrivalent Vaccines, Quadrivalent Vaccines
ProductInactivated Vaccine, Live Attenuated Vaccine, Recombinant Vaccine
TechnologyEgg-based, Cell-based, Recombinant DNA
ApplicationPediatrics, Adults, Elderly, Pregnant Women
End UserHospitals, Clinics, Pharmacies, Community Centers, Research Institutes
ProcessManufacturing, Distribution, Storage
DeploymentOn-premise, Cloud-based
FunctionalityImmunogenicity, Safety, Efficacy
ModeIntramuscular, Intranasal, Intradermal
StagePre-clinical, Clinical Trials, Post-marketing Surveillance

The influenza vaccine market is predominantly driven by the inactivated vaccine segment, with live attenuated vaccines also maintaining a significant presence. This segmentation is influenced by factors such as efficacy, safety profiles, and the varying needs of different demographic groups. Geographically, North America remains at the forefront due to robust healthcare infrastructure and awareness programs, while the Asia-Pacific region is witnessing a burgeoning demand fueled by increasing government initiatives and rising healthcare investments.

Prominent industry players, including Sanofi, GlaxoSmithKline, and CSL Limited, are continuously enhancing their portfolios through research and development. Regulatory influences, particularly in the United States and Europe, are pivotal, as stringent guidelines ensure vaccine safety and efficacy, thereby shaping market dynamics. Looking ahead, the market is anticipated to expand due to technological advancements in vaccine production and distribution. The ongoing emphasis on pandemic preparedness and the development of universal vaccines present lucrative opportunities. However, challenges such as supply chain logistics and vaccine hesitancy remain, necessitating strategic interventions to sustain growth.

Recent Developments:

The influenza vaccine market has experienced noteworthy developments over the past three months. Sanofi announced a strategic partnership with a leading biotech firm to enhance its flu vaccine production capabilities, aiming to address global demand surges. GlaxoSmithKline (GSK) launched an innovative flu vaccine in Europe, featuring enhanced efficacy against emerging strains, marking a significant milestone in vaccine technology. In the United States, the Food and Drug Administration (FDA) granted fast-track approval for a novel influenza vaccine developed by a prominent pharmaceutical company, promising quicker market entry. Meanwhile, a joint venture between a Japanese pharmaceutical giant and a European counterpart was formed to explore advanced mRNA technologies for flu vaccines, signaling a shift towards cutting-edge vaccine solutions. Furthermore, a leading vaccine manufacturer announced a substantial investment in expanding its supply chain infrastructure, ensuring robust distribution capabilities ahead of the upcoming flu season. These developments underscore the dynamic nature of the influenza vaccine market, driven by innovation and strategic collaborations.

Key Trends and Drivers:

The Influenza Vaccine Market is experiencing robust growth, driven by heightened awareness of infectious diseases and the importance of vaccination. Key trends include the development of next-generation vaccines, which offer broader protection and longer-lasting immunity. Technological advancements in vaccine production, such as cell-based and recombinant technologies, are streamlining manufacturing processes and enhancing vaccine efficacy.

The COVID-19 pandemic has underscored the critical role of vaccines in public health, leading to increased investments in vaccine research and infrastructure. Governments worldwide are prioritizing influenza vaccination programs as part of comprehensive pandemic preparedness strategies. Additionally, the expansion of immunization programs in emerging economies is significantly contributing to market growth.

There is a growing emphasis on personalized vaccines tailored to specific populations, enhancing vaccine uptake and effectiveness. Opportunities abound in digital health platforms, which facilitate efficient distribution and monitoring of vaccination campaigns. Companies that innovate in vaccine delivery methods, such as needle-free options, are poised to capture significant market share. With continuous advancements in biotechnology, the Influenza Vaccine Market is set for sustained expansion, addressing both seasonal influenza and potential pandemic threats.

Restraints and Challenges:

The influenza vaccine market is confronted with several significant restraints and challenges. A primary concern is the seasonality of influenza, which causes fluctuating demand and complicates production planning. Vaccine hesitancy, fueled by misinformation and distrust in pharmaceutical companies, further limits market penetration. Additionally, the high cost of vaccine research and development presents a significant barrier to entry for new players, stifling innovation. Regulatory hurdles, including stringent approval processes, delay the introduction of new vaccines to the market. Moreover, the need for constant updates to the vaccine strains, in response to the virus's rapid mutation, imposes a continuous financial and logistical burden on manufacturers. These challenges collectively hinder the market's growth and accessibility, impacting public health efforts to control influenza outbreaks.

Key Companies:

Seqirus, Sanofi Pasteur, Glaxo Smith Kline, Astra Zeneca, Bio Diem, Flu Gen, Novavax, Medicago, Bharat Biotech, Serum Institute of India, Sinovac Biotech, Cure Vac, Moderna, Inovio Pharmaceuticals, Altimmune, Vaxart, Dynavax Technologies, Valneva, Emergent Bio Solutions, CSL Limited

Sources:

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), European Centre for Disease Prevention and Control (ECDC), Global Alliance for Vaccines and Immunization (GAVI), United Nations Children's Fund (UNICEF), The Bill & Melinda Gates Foundation, The Sabin Vaccine Institute, The International Vaccine Institute (IVI), The Global Influenza Surveillance and Response System (GISRS), The International Society for Influenza and other Respiratory Virus Diseases (ISIRV), The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), The World Bank, The World Economic Forum, The World Organisation for Animal Health (OIE), The Coalition for Epidemic Preparedness Innovations (CEPI), The Vaccine Confidence Project (VCP), The International Conference on Influenza Vaccines for the World (IVW), The European Society of Clinical Microbiology and Infectious Diseases (ESCMID), The American Society for Microbiology (ASM)

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Influenza Vaccine Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Influenza Vaccine Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Deployment
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by Mode
  • 2.12 Key Highlights of the Market, by Stage
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Deployment
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by Mode
  • 3.11 Market Attractiveness Analysis, by Stage
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Influenza Vaccine Market Outlook

  • 4.1 Influenza Vaccine Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Influenza Vaccine Influenza Vaccine Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Influenza Vaccine Market Size

  • 6.1 Influenza Vaccine Market Size, by Value
  • 6.2 Influenza Vaccine Market Size, by Volume

7: Influenza Vaccine Market, by Type

  • 7.1 Market Overview
  • 7.2 Trivalent Vaccines
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Quadrivalent Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Influenza Vaccine Market, by Product

  • 8.1 Market Overview
  • 8.2 Inactivated Vaccine
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Live Attenuated Vaccine
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Recombinant Vaccine
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: Influenza Vaccine Market, by Technology

  • 9.1 Market Overview
  • 9.2 Egg-based
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Cell-based
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Recombinant DNA
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Influenza Vaccine Market, by Application

  • 10.1 Market Overview
  • 10.2 Pediatrics
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Adults
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Elderly
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Pregnant Women
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Influenza Vaccine Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Pharmacies
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Community Centers
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Research Institutes
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Influenza Vaccine Market, by Process

  • 12.1 Market Overview
  • 12.2 Manufacturing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Distribution
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Storage
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Influenza Vaccine Market, by Deployment

  • 13.1 Market Overview
  • 13.2 On-premise
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Cloud-based
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Influenza Vaccine Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Immunogenicity
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Safety
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Efficacy
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Influenza Vaccine Market, by Mode

  • 15.1 Market Overview
  • 15.2 Intramuscular
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Intranasal
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Intradermal
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Influenza Vaccine Market, by Stage

  • 16.1 Market Overview
  • 16.2 Pre-clinical
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Clinical Trials
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Post-marketing Surveillance
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Influenza Vaccine Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Process
    • 17.2.8 North America Market Size and Forecast, by Deployment
    • 17.2.9 North America Market Size and Forecast, by Functionality
    • 17.2.10 North America Market Size and Forecast, by Mode
    • 17.2.11 North America Market Size and Forecast, by Stage
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Process
      • 17.2.9.7 United States Market Size and Forecast, by Deployment
      • 17.2.9.8 United States Market Size and Forecast, by Functionality
      • 17.2.9.9 United States Market Size and Forecast, by Mode
      • 17.2.9.10 United States Market Size and Forecast, by Stage
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Process
      • 17.2.10.7 Canada Market Size and Forecast, by Deployment
      • 17.2.10.8 Canada Market Size and Forecast, by Functionality
      • 17.2.10.9 Canada Market Size and Forecast, by Mode
      • 17.2.10.10 Canada Market Size and Forecast, by Stage
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Process
    • 17.3.8 Europe Market Size and Forecast, by Deployment
    • 17.3.9 Europe Market Size and Forecast, by Functionality
    • 17.3.10 Europe Market Size and Forecast, by Mode
    • 17.3.11 Europe Market Size and Forecast, by Stage
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Process
      • 17.3.10.7 Germany Market Size and Forecast, by Deployment
      • 17.3.10.8 Germany Market Size and Forecast, by Functionality
      • 17.3.10.9 Germany Market Size and Forecast, by Mode
      • 17.3.10.10 Germany Market Size and Forecast, by Stage
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Process
      • 17.3.11.7 France Market Size and Forecast, by Deployment
      • 17.3.11.8 France Market Size and Forecast, by Functionality
      • 17.3.11.9 France Market Size and Forecast, by Mode
      • 17.3.11.10 France Market Size and Forecast, by Stage
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Process
      • 17.3.12.7 Spain Market Size and Forecast, by Deployment
      • 17.3.12.8 Spain Market Size and Forecast, by Functionality
      • 17.3.12.9 Spain Market Size and Forecast, by Mode
      • 17.3.12.10 Spain Market Size and Forecast, by Stage
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Process
      • 17.3.13.7 Italy Market Size and Forecast, by Deployment
      • 17.3.13.8 Italy Market Size and Forecast, by Functionality
      • 17.3.13.9 Italy Market Size and Forecast, by Mode
      • 17.3.13.10 Italy Market Size and Forecast, by Stage
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Process
      • 17.3.14.7 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.9 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.10 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Process
      • 17.3.15.7 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.9 Sweden Market Size and Forecast, by Mode
      • 17.3.15.10 Sweden Market Size and Forecast, by Stage
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Process
      • 17.3.16.7 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.9 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.10 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Process
      • 17.3.17.7 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.9 Denmark Market Size and Forecast, by Mode
      • 17.3.17.10 Denmark Market Size and Forecast, by Stage
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Process
      • 17.3.18.7 Finland Market Size and Forecast, by Deployment
      • 17.3.18.8 Finland Market Size and Forecast, by Functionality
      • 17.3.18.9 Finland Market Size and Forecast, by Mode
      • 17.3.18.10 Finland Market Size and Forecast, by Stage
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Process
      • 17.3.19.7 Russia Market Size and Forecast, by Deployment
      • 17.3.19.8 Russia Market Size and Forecast, by Functionality
      • 17.3.19.9 Russia Market Size and Forecast, by Mode
      • 17.3.19.10 Russia Market Size and Forecast, by Stage
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Process
      • 17.4.9.7 China Market Size and Forecast, by Deployment
      • 17.4.9.8 China Market Size and Forecast, by Functionality
      • 17.4.9.9 China Market Size and Forecast, by Mode
      • 17.4.9.10 China Market Size and Forecast, by Stage
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Process
      • 17.4.10.7 India Market Size and Forecast, by Deployment
      • 17.4.10.8 India Market Size and Forecast, by Functionality
      • 17.4.10.9 India Market Size and Forecast, by Mode
      • 17.4.10.10 India Market Size and Forecast, by Stage
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Process
      • 17.4.11.7 Japan Market Size and Forecast, by Deployment
      • 17.4.11.8 Japan Market Size and Forecast, by Functionality
      • 17.4.11.9 Japan Market Size and Forecast, by Mode
      • 17.4.11.10 Japan Market Size and Forecast, by Stage
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Process
      • 17.4.12.7 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.9 South Korea Market Size and Forecast, by Mode
      • 17.4.12.10 South Korea Market Size and Forecast, by Stage
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Process
      • 17.4.13.7 Australia Market Size and Forecast, by Deployment
      • 17.4.13.8 Australia Market Size and Forecast, by Functionality
      • 17.4.13.9 Australia Market Size and Forecast, by Mode
      • 17.4.13.10 Australia Market Size and Forecast, by Stage
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Process
      • 17.4.14.7 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.9 Singapore Market Size and Forecast, by Mode
      • 17.4.14.10 Singapore Market Size and Forecast, by Stage
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Process
      • 17.4.15.7 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.9 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.10 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Process
      • 17.4.16.7 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.9 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.10 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Process
      • 17.4.17.7 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.9 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.10 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Process
    • 17.5.8 Latin America Market Size and Forecast, by Deployment
    • 17.5.9 Latin America Market Size and Forecast, by Functionality
    • 17.5.10 Latin America Market Size and Forecast, by Mode
    • 17.5.11 Latin America Market Size and Forecast, by Stage
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Process
      • 17.5.9.7 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.9 Brazil Market Size and Forecast, by Mode
      • 17.5.9.10 Brazil Market Size and Forecast, by Stage
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Process
      • 17.5.10.7 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.9 Mexico Market Size and Forecast, by Mode
      • 17.5.10.10 Mexico Market Size and Forecast, by Stage
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Process
      • 17.5.11.7 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.9 Argentina Market Size and Forecast, by Mode
      • 17.5.11.10 Argentina Market Size and Forecast, by Stage
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Process
      • 17.6.10.7 UAE Market Size and Forecast, by Deployment
      • 17.6.10.8 UAE Market Size and Forecast, by Functionality
      • 17.6.10.9 UAE Market Size and Forecast, by Mode
      • 17.6.10.10 UAE Market Size and Forecast, by Stage
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Process
      • 17.6.11.7 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.9 South Africa Market Size and Forecast, by Mode
      • 17.6.11.10 South Africa Market Size and Forecast, by Stage
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Seqirus
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Sanofi Pasteur
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 GlaxoSmithKline
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 AstraZeneca
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 BioDiem
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 FluGen
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Novavax
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Medicago
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Bharat Biotech
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Serum Institute of India
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Sinovac Biotech
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 CureVac
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Moderna
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Inovio Pharmaceuticals
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Altimmune
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Vaxart
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Dynavax Technologies
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Valneva
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Emergent BioSolutions
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 CSL Limited
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis